Zoetis (ZTS) Capital Expenditures (2012 - 2026)
Zoetis' (ZTS) quarterly Capital Expenditures came in at $117.0 million in Q2 2026, down 19.86% year-over-year from $146.0 million in Q2 2025, and up 6.36% quarter-over-quarter from $110.0 million in Q1 2026.
Analysis
Zoetis (ZTS) Capital Expenditures (2012 - 2026) Analysis & Trends
Zoetis (ZTS) has reported Capital Expenditures for 15 consecutive years, with $117.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Capital Expenditures fell 19.86% year-over-year to $117.0 million in Q2 2026; TTM through Jun 2026 was $524.0 million, a 25.88% decrease from a year earlier, with the FY2025 full-year figure at $621.0 million, down 5.19% from the prior year.
- Capital Expenditures was $117.0 million for Q2 2026 at Zoetis, up from $110.0 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $223.0 million in Q1 2023 and troughed at $110.0 million in Q1 2026.
- A 5-year average of $156.7 million and a median of $150.0 million in 2022 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures jumped 93.91% in 2023 and sank 38.2% in 2026, its largest moves.
- Over 5 years, Capital Expenditures stood at $171.0 million in 2022, then increased by 15.79% to $198.0 million in 2023, then climbed by 9.09% to $216.0 million in 2024, then retreated by 25.46% to $161.0 million in 2025, then dropped by 27.33% to $117.0 million in 2026.
- The last three Capital Expenditures figures came in at $117.0 million (Q2 2026), $110.0 million (Q1 2026), and $161.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.60 Bn | 40.40 Bn | 779.09 Mn | 24.65 Mn |
| 2 | Zoetis | 30.59 Bn | 28.91 Bn | 1.05 Bn | 117.00 Mn |
| 3 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 33.00 Mn |
| 4 | Phibro Animal Health | 1.50 Bn | 1.42 Bn | 134.40 Mn | 18.87 Mn |
| 5 | Immucell | 89.92 Mn | 81.06 Mn | 2.44 Mn | - |
| 6 | Zhengye Biotechnology Holding | 74.81 Mn | 67.72 Mn | - | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - | 55,116.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 117.00 Mn |
| Mar 31, 2026 | 110.00 Mn |
| Dec 31, 2025 | 161.00 Mn |
| Sep 30, 2025 | 136.00 Mn |
| Jun 30, 2025 | 146.00 Mn |
| Mar 31, 2025 | 178.00 Mn |
| Dec 31, 2024 | 216.00 Mn |
| Sep 30, 2024 | 167.00 Mn |
| Jun 30, 2024 | 132.00 Mn |
| Mar 31, 2024 | 140.00 Mn |
| Dec 31, 2023 | 198.00 Mn |
| Sep 30, 2023 | 145.00 Mn |
| Jun 30, 2023 | 166.00 Mn |
| Mar 31, 2023 | 223.00 Mn |
| Dec 31, 2022 | 171.00 Mn |
| Sep 30, 2022 | 154.00 Mn |
| Jun 30, 2022 | 146.00 Mn |
| Mar 31, 2022 | 115.00 Mn |
| Dec 31, 2021 | 168.00 Mn |
| Sep 30, 2021 | 119.00 Mn |